1. McCullers JA. the co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol 2014. 12: 252-62. • 2. Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet 2020; 395: 470-3. • 3. McAleer JP, Kolls, JK. Contributions of the intestinal microbiome in lung immunity. Eur J Immunol 2018; 48: 39-49. • 4. Budden KF, Gellatly SL, Wood dLA, et al. Emerging pathogenic links between microbiota and the gut-lung axis. Nat Rev Microbiol 2017; 15: 55-63. • 5. Gu S, Chen Y, Wu Z, et al. Alterations of the gut microbiota in patients with CoVid-19 or H1N1 influenza. Clin Infect Dis 2020 (in press). • 6. Wang J, Li F, Wei H, et al. Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated th17 cell-dependent inflammation. J Exp Med 2014; 211: 2397-410. • 7. deriu E, Boxx GM, He X, et al. influenza Virus Affects intestinal microbiota and secondary Salmonella infection in the gut through type i interferons. PLoS Pathog 2016; 12: e1005572. • 8. Groves Ht, Cuthbertson L, James P, et al. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol 2018; 9: 182-93. • 9. Sencio V, Barthelemy A, tavares LP, et al. Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep 2020; 30: 2934-47. • 10. Zuo t, Zhang F, Lui GCY, et al. Alterations in gut microbiota of patients with CoVid-19 during time of hospitalization. Gastroenterology 2020 (in press). • 11. Zuo t, Zhan H, Zhang F, et al. Alterations in fecal fungal microbiome of patients with CoVid-19 during time of hospitalization until discharge. Gastroenterology. 2020 pii: S0016-5085(20)34852-6. • 12. Groves Ht, Higham SL, Moffatt MF, et al. Respiratory viral infection alters the gut microbiota by inducing inappetence. mBio 2020; 11: e03236-19. • 13. trottein F, Sokol H. Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection. Cell Rep 2020; 32: 107915. • 14. openshaw PJ. Crossing barriers: infections of the lung and the gut. Muc Immunol 2009; 2: 100-2. • 15. Koh A, de Vadder F, Kovatcheva-datchary P, et al. From dietary fiber to host physiology: short-chain fatty Acids as key bacterial metabolites. Cell 2016; 165: 1332-5. • 16. Brown RL, Sequeira RP and Clarke tB. the microbiota protects against respiratory infection via GM-CSF signaling. Nat Commun 2017; 8: 1512-22. • 17. Zelaya H, Alvarez S, Kitazawa H, et al. Respiratory antiviral immunity and immunobiotics: beneficial effects on inflammation-coagulation interaction during influenza virus infection. Front Immunol 2016; 7: 633. • 18. d'Ettorre G, Ceccarelli G, Marazzato M, et al. Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of CoVid-19. Front Medecine 2020; 7: 389-96.